Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination.

Frontiers in cellular and infection microbiology

Volumn 2, Issue , 2012, Pages 67-

  Zlosnik, James E A ^a   Gunaratnam, L Cynthia ^b   Speert, David P ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT;

ARTICLE; BACTEREMIA; BIOSCREEN; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTION; CEPACIA SYNDROME; CYSTIC FIBROSIS; EVALUATION STUDY; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOLOGY; METHODOLOGY; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SERUM; SERUM BACTERICIDAL ACTIVITY;

BIOSCREEN; BURKHOLDERIA CEPACIA COMPLEX; CEPACIA SYNDROME; COMPLEMENT; CYSTIC FIBROSIS; SERUM;

BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD BACTERICIDAL ACTIVITY; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICROBIAL VIABILITY;

EID: 84881612516     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2012.00067     Document Type: Article

References (0)